Immuno-Oncologic Profiling by Stage-Dependent Transcriptome and Proteome Analyses of Spontaneously Regressing Canine Cutaneous Histiocytoma [NanoString]

Strong Correlation of Gene Counts and Differentially Expressed Genes between a 3′ RNA-Seq and RNA Hybridisation Platform from Canine Archival Tissue [nCounter]

Strong Correlation of Gene Counts and Differentially Expressed Genes between a 3′ RNA-Seq and RNA Hybridisation Platform from Canine Archival Tissue [NanoString]

Characterization of resistance to tumor-localized interleukin-2 and interleukin-12 therapy in pet dogs with advanced malignant melanoma

The transcriptomic profile of peripheral blood nuclear cells in dogs with atopic dermatitis before and after 6 months allergen-specific immunotherapy.

Gene expression profile of canine Chimeric Antigen Receptor (CAR) Engineered invariant Natural Killer T (iNKT) cells

Gene expression signatures of MDCK-pTR GFP-RasV12 cells cultured alone or mixed with MDCK cells

Collagen-anchored interleukin-2 and interleukin-12 safely reprogram the tumor microenvironment in canine soft tissue sarcomas

Collagen-anchored interleukin-2 and interleukin-12 safely reprogram the tumor microenvironment in soft tissue sarcomas

Gene expression signatures of MDCK-pTR GFP-RasV12 mCherry-β-catenin Δ131 cells cultured alone or mixed with MDCK mCherry-β-catenin Δ131 cells

Canine head and neck cancer as a spontaneous, translational model for radio-immunology research

Global gene expression of canine bladder K9TCC cells and cancer stem cells after COX-2 inhibition

Gene expression analysis in canine discoid/chronic lupus erythematosus, mucocutaneous lupus erythematosus and lupoid drug reaction

Gene expression analysis in complex canine chronic cutaneous lupus erythematosus (CCLE)

Time-course study of microarray transcriptome analysis in influenza virus-infected MDCK and TR7 cells.

Predictive Models of Drug Response in Canine Osteosarcoma: A Prospective Clinical Trial Testing the COXEN Approach

Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma [array]

Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma

Canine osteosarcoma tissues with DLG2 deletion vs. DLG2 wild type

Gene expression during CDCP1-induced morphological changes in MDCK cysts